Today: 19 May 2026
Anglo American stock slips as De Beers sale gets messier — what investors watch next
10 February 2026
1 min read

Anglo American stock slips as De Beers sale gets messier — what investors watch next

London, February 10, 2026, 08:54 GMT — Regular session

  • Anglo American slipped roughly 0.4% in early London trading, giving back a bit following Monday’s surge.
  • De Beers is back under the microscope, with Angola now seeking a 20%-30% ownership stake as the sale process picks up steam.
  • Anglo’s full-year numbers are due out February 20, and the market is watching closely.

Shares of Anglo American slipped 0.42% to 3,531 pence as of 08:54 GMT on Tuesday, after earlier gains gave way amid reports suggesting the sale of diamond arm De Beers could get trickier.

De Beers pulling out is a big deal for Anglo, since it’s central to the company’s overhaul and cash recycling strategy. Getting several governments involved might open doors politically—though it also risks dragging out the process and complicating who holds sway, how prices are set, and who calls the shots on governance.

Eyes are on the diamonds market, too. Prices keep slipping. With lab-grown stones cutting into demand for mined gems, buyers are hesitant and sellers are finding themselves with little bargaining power.

Angola wants to secure a 20% to 30% holding in De Beers and has been floating the proposal with fellow African diamond producers, a senior official at the nation’s mining ministry told Reuters. “Taking the majority stake within luxury commodities is very dangerous,” said Paulo Tanganha, who clarified Angola’s preferred range is “between 20% and 30%” for risk control. So far, discussions with Botswana, Namibia and South Africa haven’t yielded a unified stance. Reuters

Duncan Wanblad, CEO of Anglo, told the Financial Times he expects De Beers to go to a public-private consortium, aiming to close the deal within the year, Alliance News reported. Botswana will “almost certainly” lift its current 15% stake, Wanblad said, and Angola and Namibia have both shown interest. MarketScreener

Anglo American slipped early after a strong session Monday, when shares jumped 3.23% to finish at £35.46—well ahead of the broader market.

Anglo’s full-year numbers drop Feb. 20, marking the next major event for the stock. Investors are zeroed in on De Beers—specifically, valuation details and the pace of any potential exit. The context: diamond demand isn’t what it used to be, and lab-grown competition keeps ramping up.

The risks are obvious. Should new state-backed financing fall short, or if official demands clash with what private buyers are willing to accept, the sale could stall and valuations may come up short. On the diamond front, sluggish demand recovery would weigh on both profits and eventual sale prices.

Stock Market Today

  • TSMC Outperforms Nvidia as AI Chip Demand Fuels Semiconductor Growth
    May 19, 2026, 10:03 AM EDT. Nvidia (NVDA) prepares to report fiscal Q1 2027 results on May 20 amid mixed stock performance. Despite strong earnings, Nvidia shares gained only 21% in six months, lagging the 73% rise in the PHLX Semiconductor Sector index. In contrast, Taiwan Semiconductor Manufacturing (TSMC), Nvidia's key foundry partner, surged 33% in 2026. TSMC leads the foundry market with a 72% share and dominates the expanding Foundry 2.0 market, integrating chip manufacturing and packaging critical for AI chips. This segment grew 16% to $320 billion in 2025, with TSMC's revenue up 36%. Research projects an 11% CAGR for Foundry 2.0 through 2030. Investors eye TSMC as a strong play in the AI semiconductor sector, potentially outperforming Nvidia post-earnings.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Vertiv shares slide ahead of AI data center update

Vertiv shares slide ahead of AI data center update

18 May 2026
Vertiv Holdings shares dropped 8.5% to $339.41 on Monday, erasing over $12 billion in market value ahead of a key investor conference. Trading volume reached about 7 million shares. The decline outpaced peers as U.S. tech stocks fell broadly. Vertiv urged shareholders to reject a mini-tender offer from Tutanota LLC for up to 500,000 shares.
RELX share price edges higher — what to watch before Thursday’s results
Previous Story

RELX share price edges higher — what to watch before Thursday’s results

India fintech MIDASX hits best quarter, turns cash-flow positive as it scales AI-led distribution
Next Story

India fintech MIDASX hits best quarter, turns cash-flow positive as it scales AI-led distribution

Go toTop